Why have there been issues around chemists prescribing for trans patients?

A lack of education and awareness around trans issues has led to a culture of fear. This hampers safe and effective provision of care for this patient group. Active anti-trans lobbyists have raised unnecessary and unfounded concerns, particularly in relation to trans youth, and this has made regulators very concerned. Although this concern appears in other countries, it seems that the UK is falling behind in understanding the need for equality in healthcare for trans patients.